Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The UNIVERSITY OF CAPE TOWN maintains a prosecution profile in the Biotechnology & Pharmaceuticals technology area featuring 5 pending office actions. Each of these actions is assigned to a different individual, as evidenced by the 5 distinct examiners currently reviewing the cases. This distribution between actions and examiners suggests that the university's research output is being evaluated through a variety of different perspectives. Furthermore, the workload is spread across 5 distinct art units, indicating a broad technical range within the biotechnology field.
The busiest examiner identified in the data is CUTLIFF, YATE KAI RENE, who is responsible for 1 busiest examiner pending office action. Since the total number of pending office actions is 5, the workload is distributed rather than being clustered under a single examiner. For the university's legal representatives, this means that prosecution tactics must be adapted for 5 different examiners across 5 distinct art units. This diversity in the examination process reduces the risk that a single examiner's interpretation will impact the entire portfolio. The alignment of 5 examiners and 5 art units suggests that each pending matter may be in a unique sub-specialty of the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| KELLY, ROBERT M | 1 | 74.1% | +24.1% |
| MYERS, CARLA J | 1 | 49.5% | +46.0% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
| DIPERT, FORREST BLAKE | 1 | 50.0% | +64.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | DEVI, SARVAMANGALA | 14d |
| 18685337 | Selective Aerobic Oxidation of Methane | CUTLIFF, YATE KAI RENE | — |
| 18553024 | TARGETS OVEREXPRESSED ON THE SURFACE OF CANCER CELLS | MYERS, CARLA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | DEVI, SARVAMANGALA | 14d |
| 18685337 | Selective Aerobic Oxidation of Methane | CUTLIFF, YATE KAI RENE | — |
| 18568456 | TOBAMOVIRUS PSEUDOVIRIONS FOR STABILISING SINGLE STRANDED RNA | KELLY, ROBERT M | — |
| 18553024 | TARGETS OVEREXPRESSED ON THE SURFACE OF CANCER CELLS | MYERS, CARLA J | — |
| 17634482 | System and Method for Infusion of Drugs | DIPERT, FORREST BLAKE | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| 1638 | 1 |
| 1682 | 1 |
| 1645 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18685337 | Selective Aerobic Oxidation of Methane | CUTLIFF, YATE KAI RENE | 1692 | §103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18568456 | TOBAMOVIRUS PSEUDOVIRIONS FOR STABILISING SINGLE STRANDED RNA | KELLY, ROBERT M | 1638 | §103 | Final Rejection | — | Pending | Dec 08, 2023 |
| 18553024 | TARGETS OVEREXPRESSED ON THE SURFACE OF CANCER CELLS | MYERS, CARLA J | 1682 | §101§103§112 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | DEVI, SARVAMANGALA | 1645 | §103§112 | Non-Final OA | 14d | Pending | May 19, 2023 |
| 17634482 | System and Method for Infusion of Drugs | DIPERT, FORREST BLAKE | 3783 | §103 | Non-Final OA | — | Pending | Feb 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITY OF CAPE TOWN has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Yate Kai Rene Cutliff has the most, with 1 of UNIVERSITY OF CAPE TOWN's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
